IRIS
RICCIO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.340
EU - Europa 699
AS - Asia 516
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 2.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.329
IT - Italia 468
SG - Singapore 201
CN - Cina 160
VN - Vietnam 124
IE - Irlanda 67
NL - Olanda 52
CI - Costa d'Avorio 39
FI - Finlandia 35
FR - Francia 14
DE - Germania 13
IN - India 13
UA - Ucraina 13
CA - Canada 10
SE - Svezia 10
BG - Bulgaria 9
GB - Regno Unito 9
TR - Turchia 5
HK - Hong Kong 4
JP - Giappone 4
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
IL - Israele 2
IR - Iran 2
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
Totale 2.599
Salva come PNG Salva come JPEG
Città #
Chandler 222
Singapore 154
Napoli 129
Dong Ket 124
Ashburn 121
Millbury 82
Naples 61
Beijing 60
Des Moines 53
Amsterdam 50
Nanjing 42
Princeton 41
Dublin 36
Santa Clara 35
Lawrence 32
Boston 28
Caserta 24
Wilmington 24
Washington 19
Jacksonville 13
Hebei 12
Los Angeles 11
Milan 11
Nanchang 10
Ottawa 10
Sciacca 10
Duncan 9
Redwood City 9
Seattle 9
Sofia 9
Jiaxing 8
Rome 8
Fairfield 6
Boardman 5
Houston 5
New York 5
Riccione 5
Sesto San Giovanni 5
Tianjin 5
Woodbridge 5
Bucharest 4
Dallas 4
Frattamaggiore 4
Hong Kong 4
Marano Di Napoli 4
Norwalk 4
Shenyang 4
Augusta 3
Baar 3
Brescia 3
Changsha 3
Istanbul 3
Maddaloni 3
Menlo Park 3
Nardò 3
Pomezia 3
San Giorgio Ionico 3
Absecon 2
Ann Arbor 2
Baronissi 2
Colorado Springs 2
Crespano Del Grappa 2
Erice 2
Formia 2
Frankfurt am Main 2
Giugliano In Campania 2
Gragnano 2
Halle 2
Hangzhou 2
Jinan 2
Las Vegas 2
Milazzo 2
Ningbo 2
Perugia 2
Piano Di Sorrento 2
Pune 2
San Mateo 2
Sant'arpino 2
Stockholm 2
Tokyo 2
Abano Terme 1
Abidjan 1
Afragola 1
Altamura 1
Ardabil 1
Bologna 1
Brno 1
Brusciano 1
Callao 1
Casalnuovo Di Napoli 1
Casalnuovo di Napoli 1
Casoria 1
Castelfranco Veneto 1
Castelpoto 1
Cellole 1
Centrale 1
Columbus 1
Cormeilles-en-Parisis 1
Curinga 1
Eboli 1
Totale 1.631
Salva come PNG Salva come JPEG
Nome #
Il nefrologo nel trattamento dell’iperammoniemia da disordini del ciclo dell’urea 120
Parapelvic cysts, a distinguishing feature of renal Fabry Disease. 72
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer 72
Immunosuppression and multiple primary malignancies in kidney transplanted patients. A single-institute study 61
6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial 60
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial 57
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study. 56
Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study 55
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group 54
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 54
Current tissue molecular markers in colorectal cancer: A literature review 53
Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media 52
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients? 50
Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations 49
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease 49
A strange epigastric pain. 47
Pituitary function and morphology in Fabry disease. 47
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 47
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography 45
ROLE OF HFR CARTRIDGE IN THE REMOVAL OF MEDIATORS OF INFLAMMATION IN HEMODIALYSIS PATIENTS 44
Cerebrovascular and Brain Abnormalities In Autosomal-Dominant Polycystic Kidney Disease: Role Of 3d Time-of-Flight Magnetic Resonance Angiography 43
Terapia enzimatica sostitutiva nella malattia di Fabry: cosa abbiamo imparato dallo switch? 41
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial 41
Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study 41
Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease. 39
Treatment with Agalsidase Alfa during Pregnancy in a Heterozygous Female with Fabry Disease 39
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995–2019 39
ADPKD and metformin: from bench to bedside 39
Optical Coherence Tomography Angiography Findings in Fabry Disease 38
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 37
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease 37
Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival 37
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 36
Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease 34
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial 34
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease 34
Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients 34
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature 33
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 33
Early Biomarkers of Fabry Nephropathy: A Review of the Literature. 33
Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data 31
Atrial septum aneurysm: an unusual manifestation in ADPKD? 31
Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies 31
Renal denervation in ADPKD: an exceptional case 31
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 31
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease 30
Nutritional treatment in chronic kidney disease: the concept of nephroprotection. 29
Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease 29
Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients 29
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 29
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis. 28
Does left ventricular function predict cardiac outcome in Anderson-Fabry disease? 28
Reduced intracranial volume in Fabry Disease: Evidence of abnormal neurodevelopment? 27
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 26
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 23
Fanconi syndrome with lysinuric protein intolerance 23
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial 23
Association between Left Atrial Deformation and Brain Involvement in Patients with Anderson-Fabry Disease at Diagnosis 23
SWITCH TO AGALSIDASE ALFA AFTER THE SHORTAGE OF AGALSIDASE BETA IN FABRY DISEASE: A SYSTEMATIC REVIEW WITH METANALYSIS OF THE LITERATURE 22
Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family 22
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 22
Layer-specific longitudinal strain in Anderson–Fabry disease at diagnosis: A speckle tracking echocardiography analysis 22
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 22
The potential use of biomarkers in predicting contrast-induced acute kidney injury. 21
Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease 21
Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact? 20
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol 20
Therapeutic advances in ADPKD: the future awaits 20
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease. 18
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept 18
The Retinal Vessel Density as a New Vascular Biomarker in Multisystem Involvement in Fabry Disease: An Optical Coherence Tomography Angiography Study 17
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial 16
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study 15
Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report. 15
Parapelvic Cysts: An Imaging Marker of Kidney Disease Potentially Leading to the Diagnosis of Treatable Rare Genetic Disorders? A Narrative Review of the Literature 14
Tolvaptan vs. somatostatin in the treatment of ADPKD: A review of the literature 14
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease Case Reports 14
Familial polycystic kidneys with no genetic confirmation: Are we sure it is ADPKD? 11
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease 10
Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study 9
Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3-5: Are They Robust? A Fragility Index Analysis 9
Assessing brain involvement in Fabry disease with deep learning and the brain‐age paradigm 9
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 9
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin 7
The Case | A patient with autosomal dominant polycystic kidney disease with an atypical kidney magnetic resonance image 6
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations 5
Totale 2.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 0 0 8 20 5 11 4 17 34 41 32 17
2020/2021300 4 3 11 6 28 18 10 16 34 13 23 134
2021/2022450 4 0 5 4 7 11 28 18 33 52 116 172
2022/2023571 75 44 26 41 55 69 9 57 97 53 30 15
2023/2024561 23 92 41 38 35 76 6 62 15 12 118 43
2024/2025238 125 97 16 0 0 0 0 0 0 0 0 0
Totale 2.816